Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
4,141,182
-
Share change
-
-533,160
-
Total reported value
-
$13,791,000
-
Price per share
-
$3.33
-
Number of holders
-
23
-
Value change
-
-$1,824,242
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2020
As of 30 Jun 2020,
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,141,182 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.